Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 23
Phase 36

Trial Status

Completed7
Terminated2
Other1

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT00130754Phase 3Completed
Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation
Graft Vs Host DiseaseStem Cell Transplantation
Principalinvestigator
NCT00361413Phase 3Terminated
Alefacept for Prevention of Graft Versus Host Disease (GVHD)
Graft Versus Host Disease
Principalinvestigator
NCT00616954Phase 3Terminated
A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT
Allogeneic Haplo-Stem Cell Transplatation (SCT)Graft Versus Host Disease
Principalinvestigator
NCT00716690Phase 1/2Unknown
Multi Donor Mismatched Stem Cell Transplantation (MDT)
Graft-Versus-Host Disease
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dana G Wolf, MD

Hadassah Medical Organization

Related
2 trials

Shared therapeutic areas:

Cytomegalovirus Infections

Worked with same sponsors:

Hadassah Medical OrganizationInstitut für Klinische und Molekulare Virologie+1 more
Collaborated on 1 trial
Similarity Score14%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaGraft vs Host DiseaseStem Cell Transplantation
Similarity Score11%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host DiseaseMultiple Myeloma
Similarity Score8%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaGraft vs Host Disease
Similarity Score8%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Graft vs Host DiseaseMultiple Myeloma
Similarity Score8%

Ravi Vij, M.D.

Washington University School of Medicine

Related
14 trials

Shared therapeutic areas:

Multiple MyelomaCytomegalovirus Infections
Similarity Score8%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Graft vs Host DiseaseMultiple Myeloma
Similarity Score8%

PEGOURIE, MD

University Hospital, Grenoble

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score4%

Michel ATTAL, MD, PhD

University Hospital, Toulouse

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score4%

AUGEL MEUNIER, MD

CHU ST PRIEST EN JAREZ

Related
1 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT00128739Phase 3PrincipalInvestigator

Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation

Graft Vs Host Disease
Completed
NCT00130741Phase 1PrincipalInvestigator

Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)

Colonic Diseases, Functional
Completed
NCT00130754Phase 3PrincipalInvestigator

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation

Graft Vs Host DiseaseStem Cell Transplantation
Completed
NCT00146978Phase 1/2PrincipalInvestigator

Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)

Graft vs Host Disease
Completed
NCT00284687Phase 3PrincipalInvestigator

Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients

Cytomegalovirus Infections
Completed
NCT00330018Phase 3PrincipalInvestigator

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

Bone Marrow TransplantationCytomegalovirus
Completed
NCT00361413Phase 3PrincipalInvestigator

Alefacept for Prevention of Graft Versus Host Disease (GVHD)

Graft Versus Host Disease
Terminated
NCT00616954Phase 3PrincipalInvestigator

A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT

Allogeneic Haplo-Stem Cell Transplatation (SCT)Graft Versus Host Disease
Terminated
NCT00716690Phase 1/2PrincipalInvestigator

Multi Donor Mismatched Stem Cell Transplantation (MDT)

Graft-Versus-Host Disease
Unknown
NCT01232712Phase 1/2PrincipalInvestigator

A Study to Assess the Safety and Efficacy of MUC1 Peptide Vaccine and hGM-CSF in Patients With MUC1-positive Tumor Malignancies

Multiple Myeloma
Completed

All 10 trials loaded